Cargando…
CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
Patients with chronic kidney disease (CKD) are affected by mineral and bone disorder (MBD), resulting in abnormalities in serum calcium (Ca), phosphorous (P) and parathyroid hormone (PTH). Changes in mineral metabolism have also been associated with higher rates of both all-cause and cardiovascular-...
Autor principal: | Cozzolino, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798086/ https://www.ncbi.nlm.nih.gov/pubmed/29423205 http://dx.doi.org/10.1093/ckj/sfx116 |
Ejemplares similares
-
Achievement of Kidney Disease: Improving Global Outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the Photo-Graphe3 study
por: Fouque, Denis, et al.
Publicado: (2018) -
Quality of care and practice patterns in anaemia management at specialist kidney clinics in Ireland: a national study
por: Stack, Austin G, et al.
Publicado: (2018) -
Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes
por: Pereira, Luciano, et al.
Publicado: (2018) -
Sevelamer reduces endothelial inflammatory response to advanced glycation end products
por: Gregório, Paulo C, et al.
Publicado: (2018) -
Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients
por: Cianciolo, Giuseppe, et al.
Publicado: (2016)